When you go to “COOKIES INCL. ALLOW US SERVICES” click, you agree to the storage of cookies on your device to improve website navigation, analyze site usage, and support our marketing efforts. For more information, see our Privacy statement.

12.9.2024

Haemo Pharma and Zimmer MedizinSysteme announce Cooperation

Haemo Pharma, a leading regenerative medicine company, announces its partnership with Zimmer MedizinSysteme.

Hämo Pharma and Zimmer MedizinSysteme: Training and presentation of new therapeutic devices

Eisenstadt, September 11, 2024

Haemo Pharma and Zimmer MedizinSysteme announce their partnership

Haemo Pharma, a leading company in the field of regenerative medicine, announces its partnership with Zimmer MedizinSysteme known.

Through this cooperation, Haemo Pharma is expanding its portfolio with innovative product lines, such as cold air therapy devices Cryo6 and Cryo7, the high-energy induction therapy EmfieldPro, the high-energy laser therapy device OptonPro, as well as the radial shockwave devices ENPuls2.0, EnpulsPro and the focused shockwave system EnShock.

“We are pleased to add Zimmer MedizinSysteme's proven technologies to our portfolio, give our customers expanded access to advanced treatments and, together with our new partner, help shape the therapies of the future. “, Mag. Markus Mateyka explains managing director of Haemo Pharma.

 
An overview of the products:

Cryo6 and Cryo7: Innovative cold therapy systems for the treatment of pain and inflammation.

EmFieldPro: A powerful magnetic field therapy device that is used for targeted rehabilitation, improved blood circulation and pain relief.

OptonPro: High-precision laser technology to promote wound healing and cell regeneration.

ENpuls 2.0, ENpulsPro, EnShock.: Efficient radial and focused shockwave therapy devices to treat musculoskeletal problems and improve tissue repair.

Für weitere Informationen kontaktieren Sie bitte:

More posts

Event

Review: Successful start of the QKG basic course “Cartilage Specialists” in Graz

Successful basic QKG course in Graz: Current developments in cartilage therapy.
Product Update

HyaloFast® receives MDR certification

Hyalofast® receives MDR approval and sets new standards in cartilage regeneration.
Event

Knee+Ski 2025 — expert knowledge and innovations in knee surgery

The premiere of the Knee+Ski Congress took place in Fieberbrunn from February 19 to 23, 2025.

Make evidence-based decisions

Learn more about our scientifically researched products. Please feel free to contact us for further information.